123 related articles for article (PubMed ID: 38361210)
1. CD14
Zhou J; Xiao H; Wang Z; Wang H; Liang X; Zhai Z; Hong J
Immunol Cell Biol; 2024 Apr; 102(4):256-268. PubMed ID: 38361210
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
4. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
Marini O; Spina C; Mimiola E; Cassaro A; Malerba G; Todeschini G; Perbellini O; Scupoli M; Carli G; Facchinelli D; Cassatella M; Scapini P; Tecchio C
Oncotarget; 2016 May; 7(19):27676-88. PubMed ID: 27050283
[TBL] [Abstract][Full Text] [Related]
5. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
6. Expansion of CD10
Fraccarollo D; Neuser J; Möller J; Riehle C; Galuppo P; Bauersachs J
Elife; 2021 Jul; 10():. PubMed ID: 34289931
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin's lymphoma patients.
Wang Y; Wang J; Zhu F; Wang H; Yi L; Huang K; Zhai Z
Immun Inflamm Dis; 2022 May; 10(5):e616. PubMed ID: 35478441
[TBL] [Abstract][Full Text] [Related]
8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
9. Low-density neutrophils in chronic graft versus host disease (cGVHD) are primarily immature CD10
Matthews NC; Burton CS; Alfred A
Clin Exp Immunol; 2021 Aug; 205(2):257-273. PubMed ID: 33932293
[TBL] [Abstract][Full Text] [Related]
10. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma.
Uckun FM; Song CW; Nesbit M; Kersey JH; Ramsay NK
Int J Radiat Oncol Biol Phys; 1992; 24(4):705-12. PubMed ID: 1429095
[TBL] [Abstract][Full Text] [Related]
12. Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma.
Vari F; Gandhi MK
Immunotherapy; 2011 Jun; 3(6):723-6. PubMed ID: 21668308
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
15. High percentages of peripheral blood T-cell activation in childhood Hodgkin's lymphoma are associated with inferior outcome.
Cai F; Gao H; Yu Z; Zhu K; Gu W; Guo X; Xu X; Shen H; Shu Q
Front Med (Lausanne); 2022; 9():955373. PubMed ID: 36035394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
Sato Y; Shimizu K; Shinga J; Hidaka M; Kawano F; Kakimi K; Yamasaki S; Asakura M; Fujii SI
Oncoimmunology; 2015 Mar; 4(3):e995541. PubMed ID: 25949922
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
18. Infusion of autograft natural killer cell/CD14
Kansagra A; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN; Porrata LF
Bone Marrow Transplant; 2018 Feb; 53(2):146-154. PubMed ID: 29035394
[TBL] [Abstract][Full Text] [Related]
19. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
Huang A; Zhang B; Wang B; Zhang F; Fan KX; Guo YJ
Cancer Immunol Immunother; 2013 Sep; 62(9):1439-51. PubMed ID: 23760662
[TBL] [Abstract][Full Text] [Related]
20. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
